Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Immunogen
Immunogen
After FDA Approval, A New And Bigger Catalyst Looms Closer For Immunogen
Seeking Alpha
Mon, 03/11/13 - 11:09 am
Immunogen
trastuzumab
breast cancer
This FDA Approval Is Actually a Big Deal
Motley Fool
Wed, 02/27/13 - 12:40 pm
Kadcyla
Roche
Immunogen
This Week in Biotech
Motley Fool
Sun, 02/24/13 - 02:20 pm
Roche
Immunogen
Repros Therapeutics
Chelsea Therapeutics
Gilead Sciences
Vivus
ImmunoGen Progresses with IMGN901
Yahoo/Zacks
Fri, 02/15/13 - 11:41 am
Immunogen
IMGN901
small cell lung cancer
ImmunoGen, Surprisingly Quiet Ahead Of FDA Decision
Seeking Alpha
Thu, 02/14/13 - 11:17 am
Immunogen
FDA
trastuzumab
Roche
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Sun, 01/27/13 - 11:18 am
Theravance
GSK
Astellas
Vivus
Eli Lilly
Immunogen
Roche
M&A
Don't Worry About Immunogen's Disappointing Quarter
Motley Fool
Sat, 01/26/13 - 11:53 am
Immunogen
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Fri, 01/25/13 - 10:40 am
Vivus
Theravance
Roche
MAP Pharmaceuticals
M&A
Immunogen
GSK
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
JPMorgan Healthcare Conference Highlights: ImmunoGen
Motley Fool
Tue, 01/8/13 - 10:24 am
JPMHC 2013
Immunogen
Keep an Eye on These Five New Drugs in the First Quarter of 2013
Minyanville
Thu, 12/27/12 - 10:16 pm
Rytary
GSK
Impax Labs
Celgene
pomalidomide
Roche
T-DM1
Immunogen
Eliquis
Pfizer
Bristol-Myers Squibb
Biogen Idec
BG-12
ImmunoGen's Press Release Is More Than Mere News
Seeking Alpha
Tue, 12/4/12 - 01:33 pm
Immunogen
Targeted Antibody Payload
ImmunoGen Is Living Life in the Fast Lane
Motley Fool
Thu, 11/8/12 - 12:07 pm
Immunogen
Roche
T-DM1
breast cancer
Why ImmunoGen’s Shares Had a Bad Reaction
Motley Fool
Sat, 10/27/12 - 11:34 am
Immunogen
ImmunoGen's CEO Discusses F1Q13 Results - Earnings Call Transcript
Seeking Alpha
Sat, 10/27/12 - 11:28 am
Immunogen
ImmunoGen 1st-quarter grows by 29 pct as it studies lung cancer drug and other products
Yahoo/AP
Fri, 10/26/12 - 11:12 am
earnings
Immunogen
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Roche Hosts An Encouraging Investor Day
Seeking Alpha
Thu, 09/6/12 - 04:15 pm
Roche
JNJ
Immunogen
Abbott Labs
Illumina
3 Things to Watch With ImmunoGen
Motley Fool
Wed, 08/29/12 - 12:13 pm
Immunogen
ImmunoGen Rises On Partner Roche’s Results
Bloomberg
Tue, 08/28/12 - 11:22 am
breast cancer
Roche
Immunogen
T-DM1
Upcoming Catalysts For Exelixis And Immunogen
Seeking Alpha
Mon, 08/27/12 - 10:32 am
Exelixis
Immunogen
prostate cancer
breast cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »